[HTML][HTML] SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63
BA Woldemeskel, CC Garliss… - The Journal of clinical …, 2021 - Am Soc Clin Investig
Recent studies have shown T cell cross-recognition of SARS-CoV-2 and common cold
coronavirus spike proteins. However, the effect of SARS-CoV-2 vaccines on T cell responses to …
coronavirus spike proteins. However, the effect of SARS-CoV-2 vaccines on T cell responses to …
The BNT162b2 mRNA vaccine elicits robust humoral and cellular immune responses in people living with human immunodeficiency virus (HIV)
BA Woldemeskel, AH Karaba, CC Garliss… - Clinical Infectious …, 2022 - academic.oup.com
Previous studies have shown that certain vaccines induce suboptimal responses in people
living with human immunodeficiency virus (HIV, PLWH). However, responses to severe acute …
living with human immunodeficiency virus (HIV, PLWH). However, responses to severe acute …
[HTML][HTML] Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses
…, B Zhang, BA Woldemeskel, CC Garliss… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Recent studies have reported T cell immunity to the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in unexposed donors, possibly due to …
respiratory syndrome coronavirus 2 (SARS-CoV-2) in unexposed donors, possibly due to …
[HTML][HTML] Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2
BA Woldemeskel, AK Kwaa, CC Garliss… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND T cell responses to the common cold coronaviruses have not been well
characterized. Preexisting T cell immunity to severe acute respiratory syndrome coronavirus 2 (…
characterized. Preexisting T cell immunity to severe acute respiratory syndrome coronavirus 2 (…
[HTML][HTML] CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses
…, AG Dykema, CC Garliss… - The Journal of …, 2022 - Am Soc Clin Investig
Recent studies have shown that vaccinated individuals harbor T cells that can cross-recognize
SARS-CoV-2 and endemic human common cold coronaviruses. However, it is still …
SARS-CoV-2 and endemic human common cold coronaviruses. However, it is still …
mRNA vaccine-elicited severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific T cells persist at 6 months and recognize the delta variant
BA Woldemeskel, CC Garliss… - Clinical Infectious …, 2022 - academic.oup.com
Little is known about the decay kinetics of coronavirus disease 2019 vaccine–elicited severe
acute respiratory syndrome coronavirus 2–specific T cells. In this study we show a modest …
acute respiratory syndrome coronavirus 2–specific T cells. In this study we show a modest …
[HTML][HTML] Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection
…, JR Shapiro, I Sitaras, BA Woldemeskel, CC Garliss… - JCI insight, 2022 - ncbi.nlm.nih.gov
Benchmarks for protective immunity from infection or severe disease after SARS-CoV-2
vaccination are still being defined. Here, we characterized virus neutralizing and ELISA antibody …
vaccination are still being defined. Here, we characterized virus neutralizing and ELISA antibody …
[HTML][HTML] SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge
BA Woldemeskel, CC Garliss, TY Aytenfisu… - JCI insight, 2022 - ncbi.nlm.nih.gov
Background Breakthrough SARS-CoV-2 infections in vaccinated individuals have been
previously associated with suboptimal humoral immunity. However, less is known about …
previously associated with suboptimal humoral immunity. However, less is known about …
[HTML][HTML] SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection
AG Dykema, B Zhang, BA Woldemeskel, CC Garliss… - …, 2022 - thelancet.com
Background COVID-19 mRNA vaccines elicit strong T and B cell responses to the SARS-CoV-2
spike glycoprotein in both SARS-CoV-2 naïve and experienced patients. However, it is …
spike glycoprotein in both SARS-CoV-2 naïve and experienced patients. However, it is …
[HTML][HTML] Long-term remission despite clonal expansion of replication-competent HIV-1 isolates
RT Veenhuis, AK Kwaa, CC Garliss, R Latanich… - JCI insight, 2018 - ncbi.nlm.nih.gov
Clonal expansion of T cells harboring replication-competent virus has recently been demonstrated
in patients on suppressive antiretroviral therapy (ART) regimens. However, there has …
in patients on suppressive antiretroviral therapy (ART) regimens. However, there has …